Genopharm Ltd in London, W1B 3HH

Description

Data updated on: 01-11-2023

Located at 3rd Floor, London W1B 3HH Genopharm Ltd is a Private Limited Company registered under the 04253362 registration number. It appeared on 2001-07-17. Since 2015-09-30 Genopharm Ltd is no longer under the name Novachem Industries. This firm's Standard Industrial Classification Code is 46460 which means Wholesale of pharmaceutical goods. Genopharm Limited reported its account information for the period up to 2022-07-31. The firm's most recent annual confirmation statement was submitted on 2023-05-25.

This company has one managing director this particular moment leading the company, specifically Klavdiia D. who has been carrying out the director's tasks for twenty three years. Since 2001-07-20 Mark R., had been fulfilling assigned duties for this specific company up to the moment of the resignation nine years ago.

Klavidia D. is the individual who controls this firm, owns over 3/4 of company shares.

Previous company's names
Genopharm Ltd 2015-09-30
Novachem Industries Ltd 2001-07-17

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-07-31	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2020-07-31	2021-07-31	2022-07-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	105 490	105 490	105 490	105 490	105 490	95 827

Balance Sheet
Cash Bank On Hand								1 539	5 328	22 260	33 779	943 153
Current Assets	416 988	416 988	416 988	416 988	416 988	266 764	506 001	54 346	686 050	992 838	973 253	1 150 553
Debtors	416 954	416 954	416 954	416 954	416 954			52 807	680 722	970 578	939 474	207 400
Net Assets Liabilities						95 828	31 545	47 827	56 896	83 344	104 935	155 377
Cash Bank In Hand	34	34	34	34	34
Net Assets Liabilities Including Pension Asset Liability	105 490	105 490	105 490	105 490	105 490	95 827

Capital & Reserves
Called Up Share Capital	1 000	1 000	1 000	1 000	1 000
Profit Loss Account Reserve	104 490	104 490	104 490	104 490	104 490
Shareholder Funds	105 490	105 490	105 490	105 490	105 490	95 827

Other Financial Data
Average Number Employees During Period											1	1
Creditors						170 937	474 456	6 519	629 154	909 494	868 318	995 176
Net Current Assets Liabilities	105 490	105 490	105 490	105 490	105 490	95 827	31 545	47 827	56 896	83 344	104 935	155 377
Other Operating Expenses Format2							12 124	6 500
Profit Loss							-64 282	16 282
Raw Materials Consumables Used							924 370	246 674
Tax Tax Credit On Profit Or Loss On Ordinary Activities								3 819
Total Assets Less Current Liabilities	105 490	105 490	105 490	105 490	105 491	95 827	31 545	47 827	56 896	992 838	973 253	155 377
Turnover Revenue							872 212	273 275
Creditors Due Within One Year	311 498	311 498	311 498	311 498	311 498	170 937
Number Shares Allotted	1 000	1 000	1 000	1 000	1 000
Par Value Share	1	1	1	1	1
Share Capital Allotted Called Up Paid	1 000	1 000	1 000	1 000	1 000

Company staff

Klavdiia D.

Role: Director

Appointed: 05 November 2015

Latest update: 4 March 2024

Capital Securities Limited

Role: Corporate Secretary

Appointed: 01 November 2002

Resigned: 30 November 2022

Address: London, W1B 3HH, United Kingdom

Latest update: 4 March 2024

Mark R.

Role: Director

Appointed: 20 July 2001

Resigned: 05 November 2015

Latest update: 4 March 2024

Homeric Limited

Role: Corporate Nominee Secretary

Appointed: 17 July 2001

Resigned: 01 November 2002

Address: Station Road, St Johns, Isle Of Man, IM4 3AJ

Latest update: 4 March 2024

Albany Managers Limited

Role: Corporate Nominee Director

Appointed: 17 July 2001

Resigned: 20 July 2001

Address: Anguilla, British West Indies

Latest update: 4 March 2024

People with significant control

Klavidia D.

Notified on 1 July 2016

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	30 April 2024
Account last made up date	31 July 2022
Confirmation statement next due date	08 June 2024
Confirmation statement last made up date	25 May 2023

Annual Accounts 18 April 2013
Start Date For Period Covered By Report	2011-08-01
End Date For Period Covered By Report	2012-07-31
Date Approval Accounts	18 April 2013
Annual Accounts 10 April 2014
Start Date For Period Covered By Report	2012-08-01
End Date For Period Covered By Report	2013-07-31
Date Approval Accounts	10 April 2014
Annual Accounts 23 April 2015
Start Date For Period Covered By Report	2013-08-01
End Date For Period Covered By Report	2014-07-31
Date Approval Accounts	23 April 2015
Annual Accounts 21 April 2016
Start Date For Period Covered By Report	2014-08-01
End Date For Period Covered By Report	2015-07-31
Date Approval Accounts	21 April 2016
Annual Accounts 20 November 2017
Start Date For Period Covered By Report	2015-08-01
End Date For Period Covered By Report	2016-07-31
Date Approval Accounts	20 November 2017
Annual Accounts
Start Date For Period Covered By Report	2016-08-01
End Date For Period Covered By Report	2017-07-31
Annual Accounts
Start Date For Period Covered By Report	01 August 2017
End Date For Period Covered By Report	31 July 2018
Annual Accounts
Start Date For Period Covered By Report	01 August 2017
End Date For Period Covered By Report	31 July 2018
Annual Accounts
Start Date For Period Covered By Report	01 August 2017
End Date For Period Covered By Report	31 July 2018
Annual Accounts
Start Date For Period Covered By Report	01 August 2017
End Date For Period Covered By Report	31 July 2018
Annual Accounts
Start Date For Period Covered By Report	01 August 2017
End Date For Period Covered By Report	31 July 2018

Genopharm Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Klavdiia D.

Capital Securities Limited

Mark R.

Homeric Limited

Albany Managers Limited

People with significant control

Klavidia D.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies